Assessing response rates in clinical trials of treatment for relapsed or refractory multiple myeloma: a study of bortezomib and thalidomide by H Prince, Brad Schenkel and Linda Mileshkin

被引：3
作者：
Durie, B. G. M.
Rajkumar, S. V. [1 ]
机构：
[1] Aptium Oncol Inc, Cedars Sinai Outpatient Canc Ctr, Los Angeles, CA USA
[2] Mayo Clin, Div Hematol, Rochester, MN USA
来源：
LEUKEMIA | 2007年 / 21卷 / 04期
关键词：
D O I：
10.1038/sj.leu.2404574
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：821 / 821
页数：1
相关论文
共 2 条
  • [1] International uniform response criteria for multiple myeloma
    Durie, B. G. M.
    Harousseau, J-L
    Miguel, J. S.
    Blade, J.
    Barlogie, B.
    Anderson, K.
    Gertz, M.
    Dimopoulos, M.
    Westin, J.
    Sonneveld, P.
    Ludwig, H.
    Gahrton, G.
    Beksac, M.
    Crowley, J.
    Belch, A.
    Boccadaro, M.
    Turesson, I.
    Joshua, D.
    Vesole, D.
    Kyle, R.
    Alexanian, R.
    Tricot, G.
    Attal, M.
    Merlini, G.
    Powles, R.
    Richardson, P.
    Shimizu, K.
    Tosi, P.
    Morgan, G.
    Rajkumar, S. V.
    [J]. LEUKEMIA, 2006, 20 (09) : 1467 - 1473
  • [2] PRINCE H, LEUKEMIA
1